23andMe Launches Month-Long Initiative to Amplify ARRAY’s “Seat16” Program for Acclaimed Film ORIGIN by Ava DuVernay
SUNNYVALE, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) — 23andMe Holding Co. (Nasdaq:ME) (23andMe), a leading genetic health and biopharmaceutical company, announced a month-long initiative to amplify Ava DuVernay’s new film ORIGIN and the film’s groundbreaking Seat16 program. Seat16 allows anyone to gift $16 or more to purchase an ORIGIN movie ticket for a young person who might not otherwise be able to purchase a ticket to the film. For 23 days, 23andMe will donate 100 seats daily to support the program.
Related news for (ME)
- CME Group Inc. Announces Third-Quarter 2025 Financial Results
- Don’t Miss Out: MoBot’s Latest Stock Updates 10/20/25 10:00 AM
- Breaking News: MoBot’s Latest Update as of 10/20/25 09:00 AM
- Today’s Top Performers: MoBot’s Market Review 10/17/25 07:00 PM
- MoBot alert highlights: NASDAQ: VRME, NASDAQ: ATAI, NASDAQ: STKE, NASDAQ: FGI, NASDAQ: LNKS (10/17/25 06:00 PM)
